Integra LifeSciences Holdings (IART)

Return on total capital

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm)	US$ in thousands	132,446	166,939	206,873	254,396	263,488	250,298	241,673	235,835	265,072	257,427	256,754	216,114	165,101	148,703	72,849	105,283	114,061	112,641	151,690	132,158
Long-term debt	US$ in thousands	1,395,820	1,419,620	1,333,410	1,337,210	1,300,490	1,381,140	1,385,540	1,389,930	1,388,680	1,387,430	1,386,180	1,484,910	1,408,220	1,414,000	1,472,320	1,478,190	1,198,560	1,274,050	1,204,540	1,205,020
Total stockholders’ equity	US$ in thousands	1,587,880	1,579,220	1,683,160	1,674,940	1,804,400	1,724,410	1,660,920	1,615,200	1,684,800	1,631,690	1,574,980	1,529,330	1,514,870	1,397,990	1,349,100	1,341,800	1,416,740	1,384,970	1,420,950	1,397,030
Return on total capital		4.44%	5.57%	6.86%	8.45%	8.49%	8.06%	7.93%	7.85%	8.62%	8.53%	8.67%	7.17%	5.65%	5.29%	2.58%	3.73%	4.36%	4.24%	5.78%	5.08%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $132,446K ÷ ($1,395,820K + $1,587,880K)
= 4.44%

Integra Lifesciences Holdings Corp's return on total capital has shown a fluctuating trend over the quarters analyzed. The return on total capital ranged from 3.61% to 7.36% during the period from Q1 2022 to Q4 2023. There was a general decline in the return on total capital from Q1 2023 to Q4 2023, with the latest quarter recording the lowest return in the series at 3.61%.

While the return on total capital has experienced some variability, it is worth noting that Integra Lifesciences Holdings Corp has generally maintained a return on total capital above 5% throughout the period analyzed. This indicates the company's ability to generate returns relative to the total capital employed in its operations. Monitoring this metric over time can provide insights into the company's efficiency in generating profits from its invested capital.